Pharmacy
96-Week Data From CASTLE Study Continue to Show Similar Efficacy Between Once-Daily REYATAZ Ritonavi
The FINANCIAL -- Bristol-Myers Squibb Company (NYSE: BMY) on October 26 announced 96-week data from the CASTLE study, in which 74 percent...
High-Dose Influenza Vaccine Shows Increased Immune Response Among Adults 65 Years of Age and Older
The FINANCIAL -- Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced on October 26 that an investigational high-dose influenza vaccine...
Pfizer’s Novel HIV/AIDS Treatment Selzentry (Maraviroc) Demonstrates Increased Efficacy Rate
The FINANCIAL -- Patients taking Selzentry, in combination with Combivir (zidovudine/lamivudine) and selected by an enhanced sensitivity tropism test to...
Pfizer to Present Data on New Approaches to Pain and Inflammation Treatment at ACR Meeting
The FINANCIAL -- Pfizer will present data on three investigational compounds that represent potential new mechanisms for targeting pain and...
ACZ885 Phase III data show rapid, sustained clinical remission in children
The FINANCIAL -- New Phase III data demonstrate that ACZ885 (canakinumab), a biological drug in development, achieved rapid and long-lasting...
Novartis delivers sustained strong performance in first nine months of 2008
The FINANCIAL -- Commenting on the results, Dr. Daniel Vasella, Chairman and CEO of Novartis said: "Led by the enhanced performance...
Xolair anti-IgE therapy in treating children suffering from moderate-to-severe allergic asthma
The FINANCIAL -- A new clinical study shows that Xolair (omalizumab), an innovative treatment for allergic asthma in adolescents and...
Bayer Reports Progress in Clinical Program for Riociguat
The FINANCIAL -- Based on positive Phase II trial findings, Bayer Schering Pharma will move into Phase III trials with...
VEGF Trap-Eye: New Data Confirm Successes in the Treatment of Age-related Macular Degeneration
The FINANCIAL -- VEGF Trap-Eye can achieve durable improvements in visual acuity and in biologic measurement parameters in the formation...
Pfizer Speaks About Monopolistic Issues in Georgian Pharmacy Biz
The FINANCIAL -- “Georgian distributors claim that their costs are increasing. Distributors are adding from 35 to 40 percent to...
Patient Focus as a Key Success Factor in the Treatment of Atopic Dermatitis
The FINANCIAL -- Atopic dermatitis (AD) is a chronic inflammatory pruritic skin disease that affects many children and adults, often...
Sanofi-aventis strengthens its position in the Dow Jones Sustainability World Index
The FINANCIAL -- For the second year running, sanofi-aventis affirms its presence in the Dow Jones Sustainability World Index (DJSI...
Sanofi-Aventis Announces Intention to Raise Offer for Zentiva to CZK 1150 in Cash per Share
The FINANCIAL -- Sanofi-Aventis and Zentiva N.V. (“Zentiva”) on September 22 announced an agreement on the unanimous recommendation by Zentiva of an...
Five year data confirm that early treatment with Betaferon at first sign of disease can delay progre
The FINANCIAL -- New data confirm that early initiation of Betaferon (interferon beta-1b) treatment in patients with a first event...
Novartis receives FDA priority review for Coartem
The FINANCIAL -- Novartis announced today that the US Food and Drug Administration (FDA) has granted priority review for Coartem...
ADVERTISEMENT
Popular Last 24h
-
Justice Department Files Voting Rights Suit Against City of Hazleton, Pennsylvania
-
Crews battle fire at Cleveland Metroparks Zoo’s Rainforest exhibit
-
Quantum Computing, Inc. Announces Private Placement of Common Stock for Proceeds of $100 Million
-
The UK Government has announced a full asset freeze against Blood and Honour.
-
Ampersand wins £22m five-year contract at London Zoo
-
Boston Calling 2025 lineup: Dave Matthews Band, Luke Combs, and Fall Out Boy to headline
-
Meta Will Test Showing EBay Listings On Facebook Marketplace. EBay Stock Jumps.
LATEST POSTS
LATESTINTERVIEWS
ADVERTISEMENT
